Canadian Public Reimbursement of Subsequent Entry Biologics (Sebs) / Biosimilars
May 1, 2015, 00:00
10.1016/j.jval.2015.03.974
https://www.valueinhealthjournal.com/article/S1098-3015(15)01031-1/fulltext
Title :
Canadian Public Reimbursement of Subsequent Entry Biologics (Sebs) / Biosimilars
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)01031-1&doi=10.1016/j.jval.2015.03.974
First page :
A168
Section Title :
Muscular-Skeletal Disorders
Open access? :
No
Section Order :
420